CHARLES RIVER LABORATORIES (CRL) Stock Price & Overview
NYSE:CRL • US1598641074
Current stock price
The current stock price of CRL is 173.89 USD. Today CRL is down by -0.58%. In the past month the price decreased by -4.1%. In the past year, price increased by 27.02%.
CRL Key Statistics
- Market Cap
- 8.561B
- P/E
- 16.92
- Fwd P/E
- 15.59
- EPS (TTM)
- 10.28
- Dividend Yield
- N/A
CRL Stock Performance
CRL Stock Chart
CRL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CRL. When comparing the yearly performance of all stocks, CRL turns out to be only a medium performer in the overall market: it outperformed 51.01% of all stocks.
CRL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CRL. Both the profitability and the financial health of CRL get a neutral evaluation. Nothing too spectacular is happening here.
CRL Earnings
On February 18, 2026 CRL reported an EPS of 2.39 and a revenue of 994.23M. The company beat EPS expectations (0.98% surprise) and missed revenue expectations (-0.27% surprise).
CRL Forecast & Estimates
23 analysts have analysed CRL and the average price target is 206.34 USD. This implies a price increase of 18.66% is expected in the next year compared to the current price of 173.89.
For the next year, analysts expect an EPS growth of 8.47% and a revenue growth -0.59% for CRL
CRL Groups
Sector & Classification
CRL Financial Highlights
Over the last trailing twelve months CRL reported a non-GAAP Earnings per Share(EPS) of 10.28. The EPS decreased by -0.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.02% | ||
| ROE | -4.56% | ||
| Debt/Equity | 0.68 |
CRL Ownership
CRL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.82 | 182.568B | ||
| DHR | DANAHER CORP | 22.51 | 135.149B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.21 | 44.15B | ||
| A | AGILENT TECHNOLOGIES INC | 17.26 | 32.635B | ||
| WAT | WATERS CORP | 20.94 | 29.846B | ||
| IQV | IQVIA HOLDINGS INC | 13.52 | 29.085B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.86 | 25.615B | ||
| ILMN | ILLUMINA INC | 24.35 | 19.476B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.45 | 18.366B | ||
| MEDP | MEDPACE HOLDINGS INC | 28.59 | 14.143B | ||
| RVTY | REVVITY INC | 16.13 | 9.943B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.472B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CRL
Company Profile
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,300 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Company Info
IPO: 2000-06-23
CHARLES RIVER LABORATORIES
251 Ballardvale St
Wilmington MASSACHUSETTS 01887 US
CEO: James C. Foster
Employees: 18300
Phone: 17812226000
CHARLES RIVER LABORATORIES / CRL FAQ
What does CRL do?
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,300 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
What is the stock price of CHARLES RIVER LABORATORIES today?
The current stock price of CRL is 173.89 USD. The price decreased by -0.58% in the last trading session.
What is the dividend status of CHARLES RIVER LABORATORIES?
CRL does not pay a dividend.
What is the ChartMill rating of CHARLES RIVER LABORATORIES stock?
CRL has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for CRL stock?
23 analysts have analysed CRL and the average price target is 206.34 USD. This implies a price increase of 18.66% is expected in the next year compared to the current price of 173.89.
What is the employee count for CRL stock?
CHARLES RIVER LABORATORIES (CRL) currently has 18300 employees.
Who owns CHARLES RIVER LABORATORIES?
You can find the ownership structure of CHARLES RIVER LABORATORIES (CRL) on the Ownership tab.